Cargando…

The Bisphenol A Induced Oxidative Stress in Non-Alcoholic Fatty Liver Disease Male Patients: A Clinical Strategy to Antagonize the Progression of the Disease

Introduction: Bisphenol A (BPA) exposure has been correlated to non-alcoholic fatty liver disease (NAFLD) development and progression. We investigated, in a clinical model, the effects of the administration of 303 mg of silybin phospholipids complex, 10 μg of vitamin D, and 15 mg of vitamin E (RealS...

Descripción completa

Detalles Bibliográficos
Autores principales: Federico, Alessandro, Dallio, Marcello, Gravina, Antonietta Gerarda, Diano, Nadia, Errico, Sonia, Masarone, Mario, Romeo, Mario, Tuccillo, Concetta, Stiuso, Paola, Morisco, Filomena, Persico, Marcello, Loguercio, Carmelina
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7277712/
https://www.ncbi.nlm.nih.gov/pubmed/32408667
http://dx.doi.org/10.3390/ijerph17103369
_version_ 1783543182174191616
author Federico, Alessandro
Dallio, Marcello
Gravina, Antonietta Gerarda
Diano, Nadia
Errico, Sonia
Masarone, Mario
Romeo, Mario
Tuccillo, Concetta
Stiuso, Paola
Morisco, Filomena
Persico, Marcello
Loguercio, Carmelina
author_facet Federico, Alessandro
Dallio, Marcello
Gravina, Antonietta Gerarda
Diano, Nadia
Errico, Sonia
Masarone, Mario
Romeo, Mario
Tuccillo, Concetta
Stiuso, Paola
Morisco, Filomena
Persico, Marcello
Loguercio, Carmelina
author_sort Federico, Alessandro
collection PubMed
description Introduction: Bisphenol A (BPA) exposure has been correlated to non-alcoholic fatty liver disease (NAFLD) development and progression. We investigated, in a clinical model, the effects of the administration of 303 mg of silybin phospholipids complex, 10 μg of vitamin D, and 15 mg of vitamin E (RealSIL, 100D, IBI-Lorenzini, Aprilia, Italy) in male NAFLD patients exposed to BPA on metabolic, hormonal, and oxidative stress-related parameters. Methods: We enrolled 32 male patients with histologic diagnosis of NAFLD and treated them with Realsil 100D twice a day for six months. We performed at baseline clinical, biochemical, and food consumption assessments as well as the evaluation of physical exercise, thiobarbituric acid reactive substances (TBARS), plasmatic and urinary BPA and estrogen levels. The results obtained were compared with those of healthy control subjects and, in the NAFLD group, between baseline and the end of treatment. Results: A direct proportionality between TBARS levels and BPA exposure was shown (p < 0.0001). The therapy determined a reduction of TBARS levels (p = 0.011), an improvement of alanine aminotransferase, aspartate aminotransferase, insulinemia, homeostatic model assessment insulin resistance, C reactive protein, tumor necrosis factor alpha (p < 0.05), an increase of conjugated BPA urine amount, and a reduction of its free form (p < 0.0001; p = 0.0002). Moreover, the therapy caused an increase of plasmatic levels of the native form of estrogens (p = 0.03). Conclusions: We highlighted the potential role of BPA in estrogen oxidation and oxidative stress in NAFLD patients. The use of Realsil 100D could contribute to fast BPA detoxification and to improve cellular antioxidant power, defending the integrity of biological estrogen-dependent pathways.
format Online
Article
Text
id pubmed-7277712
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-72777122020-06-12 The Bisphenol A Induced Oxidative Stress in Non-Alcoholic Fatty Liver Disease Male Patients: A Clinical Strategy to Antagonize the Progression of the Disease Federico, Alessandro Dallio, Marcello Gravina, Antonietta Gerarda Diano, Nadia Errico, Sonia Masarone, Mario Romeo, Mario Tuccillo, Concetta Stiuso, Paola Morisco, Filomena Persico, Marcello Loguercio, Carmelina Int J Environ Res Public Health Article Introduction: Bisphenol A (BPA) exposure has been correlated to non-alcoholic fatty liver disease (NAFLD) development and progression. We investigated, in a clinical model, the effects of the administration of 303 mg of silybin phospholipids complex, 10 μg of vitamin D, and 15 mg of vitamin E (RealSIL, 100D, IBI-Lorenzini, Aprilia, Italy) in male NAFLD patients exposed to BPA on metabolic, hormonal, and oxidative stress-related parameters. Methods: We enrolled 32 male patients with histologic diagnosis of NAFLD and treated them with Realsil 100D twice a day for six months. We performed at baseline clinical, biochemical, and food consumption assessments as well as the evaluation of physical exercise, thiobarbituric acid reactive substances (TBARS), plasmatic and urinary BPA and estrogen levels. The results obtained were compared with those of healthy control subjects and, in the NAFLD group, between baseline and the end of treatment. Results: A direct proportionality between TBARS levels and BPA exposure was shown (p < 0.0001). The therapy determined a reduction of TBARS levels (p = 0.011), an improvement of alanine aminotransferase, aspartate aminotransferase, insulinemia, homeostatic model assessment insulin resistance, C reactive protein, tumor necrosis factor alpha (p < 0.05), an increase of conjugated BPA urine amount, and a reduction of its free form (p < 0.0001; p = 0.0002). Moreover, the therapy caused an increase of plasmatic levels of the native form of estrogens (p = 0.03). Conclusions: We highlighted the potential role of BPA in estrogen oxidation and oxidative stress in NAFLD patients. The use of Realsil 100D could contribute to fast BPA detoxification and to improve cellular antioxidant power, defending the integrity of biological estrogen-dependent pathways. MDPI 2020-05-12 2020-05 /pmc/articles/PMC7277712/ /pubmed/32408667 http://dx.doi.org/10.3390/ijerph17103369 Text en © 2020 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Federico, Alessandro
Dallio, Marcello
Gravina, Antonietta Gerarda
Diano, Nadia
Errico, Sonia
Masarone, Mario
Romeo, Mario
Tuccillo, Concetta
Stiuso, Paola
Morisco, Filomena
Persico, Marcello
Loguercio, Carmelina
The Bisphenol A Induced Oxidative Stress in Non-Alcoholic Fatty Liver Disease Male Patients: A Clinical Strategy to Antagonize the Progression of the Disease
title The Bisphenol A Induced Oxidative Stress in Non-Alcoholic Fatty Liver Disease Male Patients: A Clinical Strategy to Antagonize the Progression of the Disease
title_full The Bisphenol A Induced Oxidative Stress in Non-Alcoholic Fatty Liver Disease Male Patients: A Clinical Strategy to Antagonize the Progression of the Disease
title_fullStr The Bisphenol A Induced Oxidative Stress in Non-Alcoholic Fatty Liver Disease Male Patients: A Clinical Strategy to Antagonize the Progression of the Disease
title_full_unstemmed The Bisphenol A Induced Oxidative Stress in Non-Alcoholic Fatty Liver Disease Male Patients: A Clinical Strategy to Antagonize the Progression of the Disease
title_short The Bisphenol A Induced Oxidative Stress in Non-Alcoholic Fatty Liver Disease Male Patients: A Clinical Strategy to Antagonize the Progression of the Disease
title_sort bisphenol a induced oxidative stress in non-alcoholic fatty liver disease male patients: a clinical strategy to antagonize the progression of the disease
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7277712/
https://www.ncbi.nlm.nih.gov/pubmed/32408667
http://dx.doi.org/10.3390/ijerph17103369
work_keys_str_mv AT federicoalessandro thebisphenolainducedoxidativestressinnonalcoholicfattyliverdiseasemalepatientsaclinicalstrategytoantagonizetheprogressionofthedisease
AT dalliomarcello thebisphenolainducedoxidativestressinnonalcoholicfattyliverdiseasemalepatientsaclinicalstrategytoantagonizetheprogressionofthedisease
AT gravinaantoniettagerarda thebisphenolainducedoxidativestressinnonalcoholicfattyliverdiseasemalepatientsaclinicalstrategytoantagonizetheprogressionofthedisease
AT dianonadia thebisphenolainducedoxidativestressinnonalcoholicfattyliverdiseasemalepatientsaclinicalstrategytoantagonizetheprogressionofthedisease
AT erricosonia thebisphenolainducedoxidativestressinnonalcoholicfattyliverdiseasemalepatientsaclinicalstrategytoantagonizetheprogressionofthedisease
AT masaronemario thebisphenolainducedoxidativestressinnonalcoholicfattyliverdiseasemalepatientsaclinicalstrategytoantagonizetheprogressionofthedisease
AT romeomario thebisphenolainducedoxidativestressinnonalcoholicfattyliverdiseasemalepatientsaclinicalstrategytoantagonizetheprogressionofthedisease
AT tuccilloconcetta thebisphenolainducedoxidativestressinnonalcoholicfattyliverdiseasemalepatientsaclinicalstrategytoantagonizetheprogressionofthedisease
AT stiusopaola thebisphenolainducedoxidativestressinnonalcoholicfattyliverdiseasemalepatientsaclinicalstrategytoantagonizetheprogressionofthedisease
AT moriscofilomena thebisphenolainducedoxidativestressinnonalcoholicfattyliverdiseasemalepatientsaclinicalstrategytoantagonizetheprogressionofthedisease
AT persicomarcello thebisphenolainducedoxidativestressinnonalcoholicfattyliverdiseasemalepatientsaclinicalstrategytoantagonizetheprogressionofthedisease
AT loguerciocarmelina thebisphenolainducedoxidativestressinnonalcoholicfattyliverdiseasemalepatientsaclinicalstrategytoantagonizetheprogressionofthedisease
AT federicoalessandro bisphenolainducedoxidativestressinnonalcoholicfattyliverdiseasemalepatientsaclinicalstrategytoantagonizetheprogressionofthedisease
AT dalliomarcello bisphenolainducedoxidativestressinnonalcoholicfattyliverdiseasemalepatientsaclinicalstrategytoantagonizetheprogressionofthedisease
AT gravinaantoniettagerarda bisphenolainducedoxidativestressinnonalcoholicfattyliverdiseasemalepatientsaclinicalstrategytoantagonizetheprogressionofthedisease
AT dianonadia bisphenolainducedoxidativestressinnonalcoholicfattyliverdiseasemalepatientsaclinicalstrategytoantagonizetheprogressionofthedisease
AT erricosonia bisphenolainducedoxidativestressinnonalcoholicfattyliverdiseasemalepatientsaclinicalstrategytoantagonizetheprogressionofthedisease
AT masaronemario bisphenolainducedoxidativestressinnonalcoholicfattyliverdiseasemalepatientsaclinicalstrategytoantagonizetheprogressionofthedisease
AT romeomario bisphenolainducedoxidativestressinnonalcoholicfattyliverdiseasemalepatientsaclinicalstrategytoantagonizetheprogressionofthedisease
AT tuccilloconcetta bisphenolainducedoxidativestressinnonalcoholicfattyliverdiseasemalepatientsaclinicalstrategytoantagonizetheprogressionofthedisease
AT stiusopaola bisphenolainducedoxidativestressinnonalcoholicfattyliverdiseasemalepatientsaclinicalstrategytoantagonizetheprogressionofthedisease
AT moriscofilomena bisphenolainducedoxidativestressinnonalcoholicfattyliverdiseasemalepatientsaclinicalstrategytoantagonizetheprogressionofthedisease
AT persicomarcello bisphenolainducedoxidativestressinnonalcoholicfattyliverdiseasemalepatientsaclinicalstrategytoantagonizetheprogressionofthedisease
AT loguerciocarmelina bisphenolainducedoxidativestressinnonalcoholicfattyliverdiseasemalepatientsaclinicalstrategytoantagonizetheprogressionofthedisease